Back to search

From the notice

The Defense Health Agency Contracting Activity (DHACA) intends to award a Firm Fixed Price, sole source Contract on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to DNA Script Inc, located in Cambridge, MA, under the authority of 41 U.S.C. 1901, as prescribed in RFO FAR 12.102(b) Restricting Competition for acquisitions valued over the SAT. This requirement is for the acquisition of 1 benchtop DNA synthesizer system with a preventative maintenance support contract for an additional 4 years. The benchtop unit shall meet the following minimum essential characteristics: 1. The synthesizer table-top dimensions must not exceed: 48’’ x 26’’ x 29’’. The required vacuum cabinet (freestanding) is 33’’ x 26’’ x 26’’ (inches). 2. The synthesizer shall have same-day throughput e.g. 96 oligos of 20 nucleotides in length in approximately 6 hours and 120 nucleotides in less than 24 hours 3. The synthesizer shall synthesize oligos labeled with fluorophores, quenchers, or biotin with the use of appropriate reagent kits with up to 5 colors in parallel. 4. The synthesizer shall be fully automated: oligos are synthesized, quantified, and normalized in a single synthesis run without user interaction following an approximate range of 15 to 30 minutes of setup. 5. The synthesizer shall have console software that can be installed and hosted on a stand-alone, off-network computer connected to the synthesizer. 6. The synthesizer shall have no harsh organic solven

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.